Dr Arron Tolley
Chief Executive Officer
Arron holds a Ph.D. in Molecular Biology and Biophysics from the University of Leeds and has a B.Sc. in Molecular Medicine. Arron has several years’ experience raising aptamers against complex cellular targets and model disease systems. He has developed several aptamer panels against model cell lines associated with oesophageal adenocarcinoma. These have shown promise for use as cell imaging reagents, biomarker discovery tools and as novel therapeutics. Arron still plays an active role in the R&D side of the group and is credited with the invention and development of a new aptamer based biomarker discovery platform to be offered to the life sciences industry through the aptamer group.